Esatenolol or s-atenolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263141This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H22N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DPF757BOSR, chemically known as 2-[4-[(2S)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide but generally known as s-atenolol or esatenolol, which bears US NIH Compound Identifier 175540. European Medicines Agency schedules s-atenolol or esatenolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06608MIG. The term ESATENOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 3 1997, List 38.). World Health Organization schedules esatenolol in its Anatomical Therapeutic Chemical (ATC) Classification. Esatenolol or s-atenolol bears US NLM identifiers UMLS ID C2825715 and NCI Concept Code C81661. SMILES: CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.